SynthesisAdvances in therapy2017

Cardiovascular Safety of Incretin-Based Therapies in Type 2 Diabetes: Systematic Review of Integrated Analyses and Randomized Controlled Trials.

Edoardo Mannucci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.